These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26529134)

  • 21. [Guidelines of the DGVS. Acute process. German Society of Digestive and Metabolic Diseases].
    Fleig WE;
    Z Gastroenterol; 2001 Jan; 39(1):33-8. PubMed ID: 11215362
    [No Abstract]   [Full Text] [Related]  

  • 22. Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
    Hanauer SB; Robinson M; Pruitt R; Lazenby AJ; Persson T; Nilsson LG; Walton-Bowen K; Haskell LP; Levine JG
    Gastroenterology; 1998 Sep; 115(3):525-32. PubMed ID: 9721148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The first oral budesonide: effective in an acute episode].
    MMW Fortschr Med; 2015 Jul; 157(13):74-5. PubMed ID: 26206012
    [No Abstract]   [Full Text] [Related]  

  • 24. Budesonide (Uceris) for ulcerative colitis.
    Med Lett Drugs Ther; 2013 Mar; 55(1412):23-4. PubMed ID: 23507873
    [No Abstract]   [Full Text] [Related]  

  • 25. Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis.
    Criscuoli V; Sinagra E; Cottone M
    Gastroenterology; 2013 Mar; 144(3):e23. PubMed ID: 23352592
    [No Abstract]   [Full Text] [Related]  

  • 26. Ozanimod (Zeposia) for ulcerative colitis.
    Med Lett Drugs Ther; 2021 Sep; 63(1633):147-151. PubMed ID: 34550962
    [No Abstract]   [Full Text] [Related]  

  • 27. [Steroids in inflammatory bowel disease].
    López San Román A; Garrido E
    Rev Esp Enferm Dig; 2015 Sep; 107(9):573. PubMed ID: 26334467
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply: budesonide.
    Sandborn WJ; Travis S; Ballard D
    Gastroenterology; 2013 Mar; 144(3):e23-4. PubMed ID: 23357061
    [No Abstract]   [Full Text] [Related]  

  • 30. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
    Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
    Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Budesonide-MMX in active ulcerative colitis.
    Gionchetti P; Praticò C; Rizzello F; Calafiore A; Capozzi N; Campieri M; Calabrese C
    Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):215-22. PubMed ID: 24502535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Zullow S; Fazelat A; Farraye FA
    Inflamm Bowel Dis; 2017 May; 23(5):E19. PubMed ID: 28328626
    [No Abstract]   [Full Text] [Related]  

  • 33. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
    [No Abstract]   [Full Text] [Related]  

  • 34. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Miehlke S; Heymer P; Bethke B; Bästlein E; Meier E; Bartram HP; Wilhelms G; Lehn N; Dorta G; DeLarive J; Tromm A; Bayerdörffer E; Stolte M
    Gastroenterology; 2002 Oct; 123(4):978-84. PubMed ID: 12360457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?].
    Nos Mateu P
    Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():16-21. PubMed ID: 19087859
    [No Abstract]   [Full Text] [Related]  

  • 36. Review article: Targeted drug delivery in treatment of intestinal diseases.
    Wikberg M; Ulmius J; Ragnarsson G
    Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():109-15. PubMed ID: 9467985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic absorption from prednisolone rectal foam in ulcerative colitis.
    Rodrigues C; Lennard-Jones JE; English J; Parsons DG
    Lancet; 1987 Jun; 1(8548):1497. PubMed ID: 2885491
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
    Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
    J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
    Monteleone G; Caprioli F
    Curr Opin Investig Drugs; 2007 May; 8(5):423-8. PubMed ID: 17520872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to remission with budesonide in collagenous colitis.
    Miehlke S; Madisch A; Bethke B; Stolte M
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1507-8; author reply 1508. PubMed ID: 15948819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.